AKT1 and prostate carcinoma: STIM1 knockdown inhibited migration and invasion of PC-3 and DU-145 cells through the inactivation of PI3K/Akt signaling pathway while it was also proposed as a potential target against prostate cancer metastasis (Zhou et al., 2017).